Adverse events of the yellow fever vaccine in chronic urticaria: evaluation of patients treated or not with omalizumab compared to healthy individuals☆☆☆
Sign Up to like & getrecommendations! Published in 2021 at "Anais Brasileiros de Dermatologia"
DOI: 10.1016/j.abd.2020.09.009
Abstract: urrently, the treatment of Chronic Urticaria (CU) follows n international consensus. When CU does not respond to ntihistamines for up to 4 weeks, the use of omalizumab is ecommended for at least 6 months, at… read more here.
Keywords: yellow fever; fever vaccine; events yellow; vaccine chronic ... See more keywords